A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects

Cancer

Volumn 92, Issue 4, 2001, Pages 941-949

  Beilin, Jonathan ^a,g   Harewood, Laurence ^b   Frydenberg, Mark ^c   Mameghan, Hedy ^d   Martyres, Raymond F ^e   Farish, Stephen J ^a   Yue, Chen ^a   Deam, David R ^f   Byron, Keith A ^b   Zajac, Jeffrey D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e Division of General Practice   (Australia)

^f GRIBBLES PATHOLOGY   (Australia)

^g ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Androgen receptor; Polymorphism; Prostate carcinoma; Risk factor

Indexed keywords

ADENINE; ANDROGEN RECEPTOR; CYTOSINE; GUANINE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROSTATE CARCINOMA; RECEPTOR GENE; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CASE-CONTROL STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, HORMONE-DEPENDENT; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REGRESSION ANALYSIS; RISK FACTORS; TRINUCLEOTIDE REPEATS;

EID: 0035880637     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010815)92:4<941::AID-CNCR1404>3.0.CO;2-P     Document Type: Article

References (51)

1. Cancer statistics, 2000
2. Family history of prostate cancer a multi-center case-control study in Canada
3. Familial prostate cancer the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer study
4. Family history and prostate cancer risk
5. Familial aspects of prostate cancer a case control study
6. Prostate cancer risk in U.S. blacks and whites with a family history of cancer
7. Evidence of an X-linked or recessive genetic component to prostate cancer
8. The impact of family history on early detection of prostate cancer
9. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada
10. Evidence for autosomal dominant inheritance of prostate cancer
11. Systematic population-based assessment of cancer risk in firstdegree relatives of cancer probands
12. Familial prostate cancer in Sweden. A nationwide register cohort study
13. Studies of genetic factors in prostate cancer in a twin population
14. Cancer in twins genetic and nongenetic familial risk factors
15. Mendelian inheritance of familial prostate cancer
16. Segregation analysis of prostate cancer in Sweden support for dominant inheritance
17. Association of prostate cancer risk with genetic olymorphisms in vitamin D receptor and androgen receptor
18. Polymorphic repeats in the androgen receptor gene molecular markers of prostate cancer risk
19. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
20. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer
21. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population
22. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
23. Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival
24. The androgen receptor gene GGN microsatellite and prostate cancer risk
25. Characterization and expression of a cDNA encoding the human androgen receptor
26. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: Specificity in prostate and non-prostate cell lines
27. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length
28. Abnormal androgen receptor binding affinity in subjects with Kennedy's disease (spinal and bulbar muscular atrophy)
29. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia
30. CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians
31. Staging of prostate cancer
32. Modulation of nontemplated nucleotide addition by Taq DNA polymerase: Primer modifications that facilitate genotyping
33. Categorical data analysis in public health
34. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element
35. Role of gonadal hormones in development of the sexual phenotypes
36. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration
37. Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone
38. Serum androgens associations with prostate cancer risk and hair patterning
39. Prospective study of sex hormone levels and risk of prostate cancer
40. Hormonal predictors of prostate cancer: A meta-analysis
41. Serum steroids in relation to prostate cancer risk in a case-control study (Greece)
42. Hormonal carcinogenesis
43. Androgen receptor CAG repeat lengths in prostate cancer correlation with age of onset
44. Cancer surveillance series: Interpreting trends in prostate cancer - Part 1: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
45. The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator
46. Expression and analysis of NSC-J, a novel androgen receptor interacting protein